US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Core High Dividend ETF

120.90

-0.3400-0.28%

Post-market: 120.900.00000.00%19:54 EST

Volume:720.21K

Turnover:87.39M

Market Cap:11.85B

PE:- -

High:121.68

Open:121.21

Low:120.85

Close:121.24

52wk High:124.19

52wk Low:106.01

Shares:98.05M

Float Shares:98.05M

Volume Ratio:0.98

T/O Rate:0.73%

Dividend:3.91

Dividend Rate:3.23%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment+0.91%

Fractional Shares+0.91%

Capital Flow

Inflow:

Outflow:

News

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®

Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating

RiboBio's HK IPO Journey: Balanced Pipeline and "China's Alnylam" Potential

Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HDV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","market":"US","secType":"STK","nameCN":"iShares Core High Dividend ETF","latestPrice":120.9,"timestamp":1766178000000,"preClose":121.24,"halted":0,"volume":720210,"hourTrading":{"tag":"盘后","latestPrice":120.9,"preClose":120.9,"latestTime":"19:54 EST","volume":323,"amount":39051.7312,"timestamp":1766192097650},"delay":0,"floatShares":98050000,"shares":98050000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.34,"latestTime":"12-19 16:00:00 EST","open":121.21,"high":121.68,"low":120.85,"amount":87393421.5156,"amplitude":0.006846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":121.24,"sharesOutstanding":98050000,"nav":120.862764,"aum":11850594010.2,"dividendRate":0.0323,"bidAskSpread":0.000118,"preHourTrading":{"tag":"盘前","latestPrice":121.72,"preClose":121.24,"latestTime":"09:13 EST","volume":287,"amount":34893.17874,"timestamp":1766153617581},"postHourTrading":{"tag":"盘后","latestPrice":120.9,"preClose":120.9,"latestTime":"19:54 EST","volume":323,"amount":39051.7312,"timestamp":1766192097650},"volumeRatio":0.9829763132434924,"impliedVol":0.1023,"impliedVolPercentile":0.452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","floatShares":98050000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9829763132434924,"shares":98050000,"dividePrice":3.9051,"high":121.68,"amplitude":0.006846,"preClose":121.24,"low":120.85,"week52Low":106.005,"pbRate":"--","week52High":124.19,"institutionHeld":0,"latestPrice":120.9,"eps":0,"divideRate":0.0323,"volume":720210,"delay":0,"ttmEps":0,"open":121.21,"prevYearClose":112.26,"prevWeekClose":122.96,"prevMonthClose":124.02,"prevQuarterClose":122.45,"fiveDayClose":122.96,"twentyDayClose":120.95,"sixtyDayClose":121.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HDV\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"HDV","amount":1.25288,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"HDV","amount":0.949579,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-06-16","symbol":"HDV","amount":0.91309,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2025-03-18","symbol":"HDV","amount":0.795075,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"},{"date":"2024-12-17","symbol":"HDV","amount":1.12172,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HDV\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-24","recordDate":"2015-12-29","paymentDate":"2015-12-31","value":0.715673,"currency":"USD"},{"executeDate":"2016-03-23","recordDate":"2016-03-28","paymentDate":"2016-03-30","value":0.676805,"currency":"USD"},{"executeDate":"2016-06-21","recordDate":"2016-06-23","paymentDate":"2016-06-27","value":0.679421,"currency":"USD"},{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.687623,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.655685,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HDV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HDV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581388662","title":"Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®","url":"https://stock-news.laohu8.com/highlight/detail?id=2581388662","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581388662?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183614/16259/en/Assembly-Biosciences-Presents-Positive-Phase-1b-Data-for-Next-Generation-Capsid-Assembly-Modulator-ABI-4334-at-AASLD-The-Liver-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ABI","CAM","BK4585","BK4139","ASMB","HDV"],"gpt_icon":0},{"id":"2581589057","title":"Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581589057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581589057?lang=en_us&edition=fundamental","pubTime":"2025-11-06 17:05","pubTimestamp":1762419947,"startTime":"0","endTime":"0","summary":"Needham analyst Joseph Stringer has maintained their bullish stance on VIR stock, giving a Buy rating yesterday. Joseph Stringer has given his Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vir-biotechnologys-strategic-advancements-in-hdv-and-oncology-programs-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vir-biotechnologys-strategic-advancements-in-hdv-and-oncology-programs-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV"],"gpt_icon":0},{"id":"1194327810","title":"RiboBio's HK IPO Journey: Balanced Pipeline and \"China's Alnylam\" Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1194327810","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194327810?lang=en_us&edition=fundamental","pubTime":"2025-10-31 09:16","pubTimestamp":1761873391,"startTime":"0","endTime":"0","summary":"From chronic medication to one-time or long-term interventions, small nucleic acid drugs are redefining treatment paradigms, highlighting the \"blue ocean\" potential of this market. With programmable...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4585","BK4588","EMA","HDV"],"gpt_icon":0},{"id":"2577597889","title":"Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2577597889","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577597889?lang=en_us&edition=fundamental","pubTime":"2025-10-24 18:12","pubTimestamp":1761300720,"startTime":"0","endTime":"0","summary":"BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. andRibocure Pharmaceuticals AB ,today announcedthat the European Medicines Agency  has granted Orphan Drug Designation  to RBD1016 for the treatment of Hepatitis D Virus  infection.About Hepatitis D Virus HDV is the most severe form of viral hepatitis and occurs only in individuals co-infected with hepatitis B virus . HDV accelerates liver disease progression, significantly increasing the risk of cirrhosis, liver failure, and hepatocellular carcinoma. It is estimated that 12–20 million people globally are affected by HDV, with limited therapeutic options currently available.Despite its severity, HDV remains underdiagnosed and underserved. The development of targeted therapies like RBD1016 offers a promising path forward for patients and clinicians seeking more effective and durable treatment options.Suzhou Ribo Life Science Co. Ltd. is a pioneer in advancing RNAi technology and industrializ","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ribo-granted-ema-orphan-drug-designation-for-sirna-therapeutic-rbd1016-for-hepatitis-delta-virus-hdv-infection-302593816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","ODD","HDV","IE0009354923.USD","BK4081","BK4588","BK4585","BK4183"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HDV\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.00912},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.009104}]}}